AI Article Synopsis
- A new method is introduced for using DNA dendrons to deliver biomolecules to living cells, inspired by high-density nucleic acid structures.
- The study found that DNA dendrons are absorbed by 90% of dendritic cells within an hour, providing over 20 times more DNA delivery per cell compared to linear DNA structures.
- This enhanced uptake is linked to their interaction with scavenger receptor-A, making DNA dendrons effective carriers for delivering peptides and potentially other biomolecules to cells.
Article Abstract
Herein, a method for synthesizing and utilizing DNA dendrons to deliver biomolecules to living cells is reported. Inspired by high-density nucleic acid nanostructures, such as spherical nucleic acids, we hypothesized that small clusters of nucleic acids, in the form of DNA dendrons, could be conjugated to biomolecules and facilitate their cellular uptake. We show that DNA dendrons are internalized by 90% of dendritic cells after just 1 h of treatment, with a >20-fold increase in DNA delivery per cell compared with their linear counterparts. This effect is due to the interaction of the DNA dendrons with scavenger receptor-A on cell surfaces, which results in their rapid endocytosis. Moreover, when conjugated to peptides at a single attachment site, dendrons enhance the cellular delivery and activity of both the model ovalbumin 1 peptide and the therapeutically relevant thymosin alpha 1 peptide. These findings show that high-density, multivalent DNA ligands play a significant role in dictating cellular uptake of biomolecules and consequently will expand the scope of deliverable biomolecules to cells. Indeed, DNA dendrons are poised to become agents for the cellular delivery of many molecular and nanoscale materials.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582297 | PMC |
| http://dx.doi.org/10.1021/jacs.1c07240 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Innovative gene delivery systems for retinal disease therapy.
Neural Regen Res
December 2024
Department of Ophthalmology, Songjiang Hospital and Songjiang Research Institute, Shanghai Key Laboratory of Emotions and Affective Disorders, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Article Synopsis
- The human retina has various specialized cells that work together to transmit visual signals, but genetic and age-related issues can lead to serious vision impairment or blindness.
- Current treatment options for retinal diseases are limited, highlighting the need for new therapeutic strategies, particularly cell and gene therapies that target retinal cells.
- Two main types of gene delivery systems—viral (like lentiviruses and adeno-associated viruses) and non-viral (such as liposomal technology)—are being explored for effectively delivering therapeutic genes to treat retinal diseases, each with its unique advantages and limitations.
Mitochondria-targeted nanotherapeutics: A new Frontier in neurodegenerative disease treatment.
Mitochondrion
December 2024
Inter-University Centre for Biomedical Research and Super Speciality Hospital, Thalappady, Rubber Board P.O, Kottayam, 686009 Kerala, India. Electronic address:
Mitochondria are the seat of cellular energy and play key roles in regulating several cellular processes such as oxidative phosphorylation, respiration, calcium homeostasis and apoptotic pathways. Mitochondrial dysfunction results in error in oxidative phosphorylation, redox imbalance, mitochondrial DNA mutations, and disturbances in mitochondrial dynamics, all of which can lead to several metabolic and degenerative diseases. A plethora of studies have provided evidence for the involvement of mitochondrial dysfunction in the pathogenesis of neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis.
View Article and Find Full Text PDFPAMAM-Calix-Dendrimers: Third Generation Synthesis and Impact of Generation and Macrocyclic Core Conformation on Hemotoxicity and Calf Thymus DNA Binding.
Pharmaceutics
October 2024
A.M. Butlerov Chemical Institute, Kazan Federal University, Kremlevskaya, 18, 420008 Kazan, Russia.
Article Synopsis
- * The study introduces third generation PAMAM dendrimers with a thiacalixarene core in three different conformations, found to effectively bind and compact DNA while showing improved binding efficiency with generations.
- * The findings suggest that the structural design of these dendrimers can lower hemotoxicity and potentially simplify the development of new, cost-effective drug delivery systems in nanomedicine.
Enhancing Transfection Efficacy in Glioma Cells: A Comparison of Microfluidic Manual Polypropylenimine Dendriplex Formation.
Int J Nanomedicine
November 2024
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, G4 0RE, UK.
Background: Gene therapy is a promising therapeutic approach for treating various disorders by introducing modified nucleic acids to correct cellular dysfunctions or introduce new functions. Despite significant advancements in the field, the effective delivery of nucleic acids remains a challenge, due to biological barriers and the immune system's ability to target and destroy these molecules. Due to their branched structure and ability to condense negatively charged nucleic acids, cationic dendrimers have shown potential in overcoming these challenges.
View Article and Find Full Text PDFMultifunctional PAMAM Dendrimers Carrying SAHA, 5-FU, and a Therapeutic Gene for Targeted Co-Delivery Toward Colorectal Cancer Cells.
Biotechnol J
November 2024
Medical Biotechnology, Life Sciences, TUBITAK Marmara Research Center, Kocaeli, Türkiye.
A promising approach to treat colorectal cancer (CRC) involves combining chemotherapy, epigenetics, and gene therapy to combat drug resistance. Multifunctional nanocarriers have emerged as a valuable tool for targeted CRC therapy. By delivering multiple treatments directly to cancer cells, these nanocarriers offer the potential for improved outcomes and reduced side effects.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!